Skip to content

King Pharmaceuticals KG Balance Sheet Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$62.21M+153%$24.63M-39.2%$40.52M+20.4%$33.67M+887%$3.41M-20.4%
$8.51M-9.0%$9.35M-9.9%$10.37M-9.3%$11.44M
$339.34M-11.6%$383.67M$0$0
$964.23M-4.5%$1.01B-10.7%$1.13B-2.5%$1.16B
$174.72M+0.2%$174.4M+0.2%$174.08M+0.2%$173.78M
$842.79M-4.4%$881.67M-10.6%$986.67M-2.2%$1.01B
42.5M+42,400%100K0.0%100K-99.8%42.5M
-$6.23M-621%$1.2M-93.7%$18.95M-21.0%$24.01M
$121.44M-5.3%$128.28M-10.8%$143.77M-4.2%$150.09M+3,451%$4.23M-8.2%
$964.23M-4.5%$1.01B-10.7%$1.13B-2.5%$1.16B

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are King Pharmaceuticals's total assets?
King Pharmaceuticals (KG) holds $964.2M in total assets.
How much debt does King Pharmaceuticals have?
King Pharmaceuticals carries $176.7M in total debt against $121.4M of shareholders' equity, a debt-to-equity ratio of 1.46.
How much cash does King Pharmaceuticals have?
King Pharmaceuticals holds $62.2M in cash and equivalents.
Where does King Pharmaceuticals's balance sheet data come from?
Every line is extracted from King Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.